Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Ovarian Cancer treatment details. Chemotherapy. Memorial Sloan-Kettering Cancer Center, New York, NY, United States

Survival: 35.2 months
Toxicity Grade: 5
Treatments: Chemotherapy
Country: United States
City/State/Province: New York, NY
Hospital: Memorial Sloan-Kettering Cancer Center
Journal: Link
Date: 6/2012

This phase 3 study involved platinum-sensitive recurrent ovarian, primary peritoneal, or fallopian tube cancer patients who had received prior platinum-based chemotherapy. Patients were divided into two separate treatment groups. Group A had 242 patients with a median age of 61 years, while group B had 242 patients with a median age of 60 years.

Patients in group A were treated with the chemotherapy agents gemcitabine and carboplatin.

Patients in group B were treated with the biologic therapy agent bevacizumab and the chemotherapy agents gemcitabine and carboplatin.

One treatment-related death due to heart attack was reported for group A. Grade 4 neutropenia was also reported.

One adverse event-related death due to brain hemorrhage was reported for group B. Grade 4 neutropenia and grade 3-4 high blood pressure were also reported.

The median overall survival times for groups A and B were 35.2 and 33.3 months, respectively.

This study was supported by Genentech.

Correspondence: Dr. Carol Aghajanian; email:

E-mail to a Friend Email Physician More Information